Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Silverarc Capital Management, Llc
Form 13F · Q2 2026

Silverarc Capital Management, Llc

CIK 1816307申報日 2026-08-1313F-HR 在 EDGAR 查看原始申報 ↗
$9.6亿
申報組合市值
73
持倉數量
12
Quarters on record
Top 50
持倉數量

Silverarc Capital Management, Llc——持倉

共 73 個持倉中的前 50 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1ASND Ascendis Pharma A/S206,234—$5501万5.7%
2CELC Celcuity Inc500,996+40.0%$5241万5.4%
3COGT Cogent Biosciences Inc1.3M−2.5%$4956万5.2%
4URGN Urogen Pharma Ltd1.3M−13.4%$4791万5.0%
5IMNM Immunome Inc2.0M+9.0%$4274万4.4%
6DNTH Dianthus Therapeutics Inc390,000−40.4%$3802万4.0%
7RYTM Rhythm Pharmaceuticals Inc311,461+1.8%$3458万3.6%
8ORKA Oruka Therapeutics Inc352,802+133.8%$3358万3.5%
9GLUE Monte Rosa Therapeutics Inc1.1M−44.6%$2682万2.8%
10SNDX Syndax Pharmaceuticals Inc1.2M+36.6%$2655万2.8%
11ELVN Enliven Therapeutics Inc489,382—$2484万2.6%
12IMVT Immunovant Inc619,096+49.5%$2385万2.5%
13ERAS Erasca Inc1.3M−31.8%$2314万2.4%
14SGMT Sagimet Biosciences Inc2.9M—$2263万2.4%
15ABVX Abivax Sa169,593−43.9%$2260万2.3%
16PRAX Praxis Precision Medicines I65,679−8.2%$2199万2.3%
17KOD Kodiak Sciences Inc546,256−44.9%$2128万2.2%
18DFTX Definium Therapeutics Inc400,000—$1882万2.0%
19VCYT Veracyte Inc318,001+77.0%$1868万1.9%
20GH Guardant Health Inc99,826+1.3%$1498万1.6%
21CCCC C4 Therapeutics Inc3.0M+58.6%$1416万1.5%
22ZBIO Zenas Biopharma Inc509,789−55.1%$1294万1.3%
23TRVI Trevi Therapeutics Inc678,095+32.7%$1265万1.3%
24HLXC Helix Acquisition Corp Iii1.2M−2.6%$1253万1.3%
25ALXO Alx Oncology Hldgs Inc5.7M—$1189万1.2%
26MANE Veradermics Inc95,000—$1168万1.2%
27XENE Xenon Pharmaceuticals Inc186,821−5.5%$1128万1.2%
28AVLN Avalyn Pharmaceuticals Inc330,487—$1088万1.1%
29BIIB Biogen Inc48,101−5.6%$1039万1.1%
30ACRS Aclaris Therapeutics Inc1.9M—$1030万1.1%
31CERS Cerus Corp3.5M+9.3%$1014万1.1%
32AVTX Avalo Therapeutics Inc500,402—$925万1.0%
33BNTC Benitec Biopharma Inc679,826−5.3%$910万0.9%
34PCVX Vaxcyte Inc145,000+0.0%$843万0.9%
35WGS Genedx Holdings Corp122,269—$839万0.9%
36SVRA Savara Inc1.4M−5.3%$835万0.9%
37OVID Ovid Therapeutics Inc3.1M+210.1%$834万0.9%
38ORIC Oric Pharmaceuticals Inc738,873−32.8%$800万0.8%
39CMPS Compass Pathways Plc503,382+67.8%$712万0.7%
40CGEN Compugen Ltd3.2M−4.0%$681万0.7%
41SLDB Solid Biosciences Inc668,450—$668万0.7%
42IBIO Ibio Inc3.5M+1457.7%$616万0.6%
43IRON Disc Medicine Inc82,800−57.8%$606万0.6%
44ALKS Alkermes Plc113,494−75.3%$595万0.6%
45SYRE Spyre Therapeutics Inc59,959−67.9%$532万0.6%
46ARTV Artiva Biotherapeutics Inc525,000—$509万0.5%
47CTNM Contineum Therapeutics Inc296,135−1.9%$485万0.5%
48QURE Uniqure Nv105,000—$484万0.5%
49RACC Research Alliance Corp Iii360,000—$385万0.4%
50ABEO Abeona Therapeutics Inc610,407−5.9%$377万0.4%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。